Herbalife Nutrition Survey Reveals Thai Consumers Concerned About Aging-Related Health Issues but Underestimate the Importance of Nutrition in Healthy Aging

Food and Healthcare Press Releases Friday November 24, 2017 14:46
Bangkok--24 Nov--Francom Asia

Herbalife Nutrition, a global nutrition company, recently revealed Thailand Healthy Aging Survey, of 501 Thai respondents aged 40 and above. The survey sought insights into the aging-related concerns and attitudes of Thai consumers, and revealed that while the majority of Thai consumers are very concerned about the potential health issues caused by aging and believe that active steps can be taken to help them age healthily, many of them underestimate the importance of good nutrition.

Based on the Herbalife Nutrition Thailand Healthy Aging Survey findings, 98 percent of Thai respondents are concerned about the potential health issues caused by aging, with 58 percent of respondents citing bone/joint-related, followed by eye-related (54 percent), brain-related (37 percent) and heart-related (32 percent) issues topping their list of concerns. However, despite the high levels of concern, 90 percent of respondents agree that they can take active steps to help age healthily.

Among the steps that the respondents will take to age healthily, engaging in more regular activity emerged as the top choice among 37 percent of respondents. In comparison, only 33 percent of respondents said they will most likely make better nutrition choices, and 9 percent said they will take supplements or go for more regular medical check-ups.

"We are glad to see that many Thais are more aware of the potential health issues caused by aging. However, we are concerned to see that making better nutritional choices takes lower priority on the list of steps that consumers will most likely take to help them improve the quality of their lives as they age," said Mr Suphot Rittipichaiwat, General Manager, Herbalife Nutrition Thailand. "By providing data-based information and bringing international health expert to Thailand, we hope to help people understand the crucial role of nutrition in enabling healthy aging because good nutrition really shouldn't be just an afterthought."

Besides revealing insights into the aging-related health concerns and the steps that Thai consumers are most willing to take to prevent them, the survey also uncovered the following:
  • When asked about their perception of the state of their own health, the majority - 87 percent of the respondents consider themselves equally healthy or more healthy than others.
  • However, for heart, emotional and mental health where early signs of anomalies are not easily detected, they displayed higher levels of confidence in the state of their well-being, with 92 percent, 90 percent and 94 percent of respondents considering themselves equally healthy or more healthy than others respectively, putting them at risk of overestimating the state of their own health.
  • Across Thailand, lack of time (46 percent) and lack of motivation (43 percent) were generally seen as the biggest obstacles toward healthy aging.

To provide tips on how Thai consumers can live a healthy, active life in the long run, with a focus on healthy aging, Herbalife Nutrition launched its eighth Asia Pacific Wellness Tour. Leading the Tour entourage was Dr. John Agwunobi, the Chief Health and Nutrition Officer at Herbalife Nutrition.

"At Herbalife Nutrition, we believe in taking a proactive approach to help people cultivate good nutrition habits, incorporate regular physical activity, consume the right supplements and schedule regular health check-ups for their personal well-being," said Dr. Agwunobi. "Through the Asia Pacific Wellness Tour, we will impart valuable tips and advice to help people harness the power of nutrition to help them live healthier and happier lives."

In Thailand, the Herbalife Nutrition Asia Pacific Wellness Tour featured health workshops in cooperation with Football Association of Thailand in Bangkok. During the Tour, Samantha Clayton, Herbalife Nutrition's Senior Director of Worldwide Sports Performance and Fitness, shared her expertise on a variety of nutrition and exercise connection, and sports performance.

LIKE us on Facebook for more nutrition and healthy active lifestyle tips at www.facebook.com/HerbalifeThailandOfficial and be inspired by www.instagram.com/HerbalifeThailandOfficial

Latest Press Release

Whisk#s AI-Powered Culinary Coach Named as Winner of Ascensia Diabetes Challenge

Today, at the American Diabetes Association's 78th Scientific Sessions in Orlando, Florida, Ascensia Diabetes Care has revealed that UK-based Whisk have been selected as the winner of the Ascensia Diabetes Challenge, a global innovation competition that...

Significant Blood Sugar Improvement With Xultophy(R) Compared to Insulin Glargine U-100 When Used as Add-On to Oral Diabetes Medications

Adults with type 2 diabetes treated with Xultophy(R) (insulin degludec and liraglutide injection) also experienced no change in body weight, lower rates of hypoglycaemia and a lower insulin dose at 26 weeks Xultophy(R) (insulin degludec and liraglutide...

Tresiba(R) Demonstrated Significantly Improved Blood Sugar Control and Lower Rates of Hypoglycaemia Versus Insulin Glargine U300 in Real-World Evidence Study

Adults with type 2 diabetes treated with Tresiba(R) (insulin degludec injection) had a significant reduction in HbA1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin Findings from CONFIRM - a large real-world evidence (RWE)...

Ozempic(R) Provided Greater Weight Reductions for Adults With a Baseline BMI ?25kg/m2 Than Those With Lower Baseline BMI 25kg/m2, in a SUSTAIN 7 Post-hoc Analysis

Ozempic(R) (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass index (BMI), with the greatest reductions occurring in adults...

Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 diabetes, according to findings from the PIONEER 1 phase 3a trial. The trial evaluated...

Related Topics